Science and Technology Science and Technology

Chris Schott Maintained (TEVA) at Hold with Increased Target to $56 on, Jun 10th, 2014


Published on 2024-10-25 05:10:56 - WOPRAI, Chris Schott
  Print publication without navigation


Chris Schott of JP Morgan, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $55 to $56 on, Jun 10th, 2014.

Chris has made no other calls on TEVA in the last 4 months.



There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 1 agrees with Chris's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • David Risinger of "Morgan Stanley" Upgraded from Sell to Hold and Held Target at $52 on, Friday, March 14th, 2014


These are the ratings of the 2 analyists that currently disagree with Chris

  • Liav Abraham of "Citigroup" Maintained at Strong Buy with Increased Target to $70 on, Tuesday, April 1st, 2014
  • Ami Fadia of "Leerink Swann" Upgraded from Hold to Buy on, Thursday, March 6th, 2014